Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAFLD/MAFLD”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableUnknownNCT05960396
What this trial is testing

Exploring the Mechanism of Dietary Pattern Improving MAFLD

Who this might be right for
NAFLDDiet Habit
Second Affiliated Hospital, School of Medicine, Zhejiang University 80
Not applicableLooking for participantsNCT06717828
What this trial is testing

The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Fujian Provincial Hospital 250
Testing effectiveness (Phase 2)Looking for participantsNCT05984745
What this trial is testing

Effect of CoQ10 on the Outcome of MAFLD Patients

Who this might be right for
Fatty LiverNAFLD
Ain Shams University 60
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Testing effectiveness (Phase 2)Study completedNCT04929483
What this trial is testing

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
89bio, Inc. 222
Not applicableLooking for participantsNCT07068191
What this trial is testing

Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more
Phenomen Pharma 90
Not applicableLooking for participantsNCT06503068
What this trial is testing

Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients

Who this might be right for
NAFLD
Tanta University 500
Not applicableEnrolling By InvitationNCT07564947
What this trial is testing

Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)

Who this might be right for
MAFLDFatty LiverFatty Liver, Non-alcoholic Fatty Liver Disease, NAFLD+4 more
University of Agriculture, Peshawar 40
Not applicableUnknownNCT05239260
What this trial is testing

Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR.

Who this might be right for
NAFLD/MAFLDLiver FibrosisCMR
Medical University of Vienna 150
Not applicableStudy completedNCT06344364
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,241
Post-approval studies (Phase 4)UnknownNCT06501326
What this trial is testing

Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseObesity
Affiliated Hospital of Nantong University 102
Not applicableUnknownNCT05421572
What this trial is testing

Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Fatty Liver Disease
Beijing Tsinghua Chang Gung Hospital 2,000
Not applicableNot Yet RecruitingNCT07336563
What this trial is testing

ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH)Metabolic SyndromeObesity & Overweight+2 more
Jarosław Drobnik 10,000
Not applicableUnknownNCT05520697
What this trial is testing

Exercise and Cerebral Hemodynamics in MAFLD.

Who this might be right for
Non-alcoholic Fatty Liver Disease
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 42
Not applicableStudy completedNCT06392828
What this trial is testing

EndoNAFLD: Relationship Between Fatty Liver Disease and Cardiovascular Diseases

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseCardiovascular Diseases
IMDEA Food 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07637006
What this trial is testing

Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Hong Kong Baptist University 180
Not applicableNot Yet RecruitingNCT06097338
What this trial is testing

Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF

Who this might be right for
Fatty Liver Disease, Nonalcoholic
Qianfoshan Hospital 200
Not applicableLooking for participantsNCT06585982
What this trial is testing

Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis

Who this might be right for
Fatty Liver Disease
Universitas Diponegoro 50
Not applicableUnknownNCT04861012
What this trial is testing

Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt

Who this might be right for
Steatohepatitis, Nonalcoholic
Assiut University 360
Testing effectiveness (Phase 2)UnknownNCT05966025
What this trial is testing

Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Fatty Liver DiseaseFatty Liver
October 6 University 60
Load More Results